1. Home
  2. ELVN vs JBSS Comparison

ELVN vs JBSS Comparison

Compare ELVN & JBSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELVN
  • JBSS
  • Stock Information
  • Founded
  • ELVN 2016
  • JBSS 1959
  • Country
  • ELVN United States
  • JBSS United States
  • Employees
  • ELVN N/A
  • JBSS N/A
  • Industry
  • ELVN Biotechnology: Pharmaceutical Preparations
  • JBSS Specialty Foods
  • Sector
  • ELVN Health Care
  • JBSS Consumer Staples
  • Exchange
  • ELVN Nasdaq
  • JBSS Nasdaq
  • Market Cap
  • ELVN 1.1B
  • JBSS 961.7M
  • IPO Year
  • ELVN 2020
  • JBSS 1991
  • Fundamental
  • Price
  • ELVN $22.47
  • JBSS $85.48
  • Analyst Decision
  • ELVN Strong Buy
  • JBSS
  • Analyst Count
  • ELVN 5
  • JBSS 0
  • Target Price
  • ELVN $37.80
  • JBSS N/A
  • AVG Volume (30 Days)
  • ELVN 204.7K
  • JBSS 98.1K
  • Earning Date
  • ELVN 11-13-2024
  • JBSS 01-29-2025
  • Dividend Yield
  • ELVN N/A
  • JBSS 2.63%
  • EPS Growth
  • ELVN N/A
  • JBSS N/A
  • EPS
  • ELVN N/A
  • JBSS 4.64
  • Revenue
  • ELVN N/A
  • JBSS $1,108,874,000.00
  • Revenue This Year
  • ELVN N/A
  • JBSS N/A
  • Revenue Next Year
  • ELVN N/A
  • JBSS N/A
  • P/E Ratio
  • ELVN N/A
  • JBSS $18.42
  • Revenue Growth
  • ELVN N/A
  • JBSS 13.01
  • 52 Week Low
  • ELVN $10.90
  • JBSS $79.07
  • 52 Week High
  • ELVN $30.03
  • JBSS $108.96
  • Technical
  • Relative Strength Index (RSI)
  • ELVN 39.53
  • JBSS 42.54
  • Support Level
  • ELVN $21.84
  • JBSS $88.62
  • Resistance Level
  • ELVN $24.42
  • JBSS $91.98
  • Average True Range (ATR)
  • ELVN 1.59
  • JBSS 2.28
  • MACD
  • ELVN -0.05
  • JBSS -0.14
  • Stochastic Oscillator
  • ELVN 18.27
  • JBSS 12.31

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage precision oncology company focused on the discovery and development of potentially first-in-class precision oncology therapies. Enliven's programs are designed to address issues such as tolerability, combinability, resistance and disease escape through brain metastases. Its product candidates include ELVN-001 which is a potent, selective, small molecule kinase inhibitor designed to specifically target the BCR-ABL gene fusion, the oncogenic driver for patients with chronic myeloid leukemia, and the ELVN-002 which is central nervous system (CNS) penetrant and irreversible HER2 inhibitor with activity against wild type HER2 and various HER2 mutations.

About JBSS John B. Sanfilippo & Son Inc.

John B Sanfilippo & Son Inc is one of the processors and distributors of peanuts, pecans, cashews, walnuts, almonds, and other nuts in the United States. These nuts are sold under a variety of private brands and under the Fisher, Orchard Valley Harvest, and Sunshine Country brand names. It also market and distribute, and in the majority of cases, manufacture or process, a diverse product line of food and snack products, including peanut butter, almond butter, cashew butter, candy and confections, snacks and trail mixes, snack bites, sunflower kernels, dried fruit, corn snacks, sesame sticks and other sesame snack products under private brands and brand names.

Share on Social Networks: